CancerCare® Celebrates 35th Annual Festival of Hope Gala to Raise Funds for People Impacted by Cancer
2023 Gala Raised Over $150,000 to Support its Free Emotional & Practical Support Services
CancerCare® is excited to share that its 35th Annual Festival of Hope Gala, held on May 17, 2023, at the Park Savoy, in Florham Park, NJ, raised over $150,000 to support individuals affected by cancer, along with their families. A portion of the donations will directly support the Healing Hearts Bereavement Camp, a free weekend retreat for families grieving the loss of a loved one to cancer. CancerCare is a national nonprofit organization that provides free, professional services to anyone affected by cancer, with a regional office located in Paramus, NJ.
CancerCare was proud to present its 2023 Corporate Achievement Award to Daiichi Sankyo, a global pharmaceutical company dedicated to developing novel therapies and educational resources for people with cancer, as well as other diseases with high unmet medical needs. The award was accepted by Gissoo DeCotiis, Daiichi Sankyo’s Global Head of Advocacy & Strategic Relations.
“We are incredibly grateful for the generous support of Daiichi Sankyo and all of our sponsors and donors who made this year’s Festival of Hope Gala a tremendous success. With their help, CancerCare will continue to provide vital services and support to people affected by cancer across the country,” said Kathy Nugent, LCSW, CancerCare's Senior Director of Regional Programs.
“The Daiichi Sankyo team is incredibly proud and humbled to accept this award and be part of this important event that brings together people living with cancer and those who support them,” said Gissoo DeCotiis, in her remarks. “CancerCare is an important partner as we have a shared mission to provide professional support services and practical educational information to help all people manage the emotional, financial, familial and personal challenges posed by cancer.”
In addition to Daiichi Sankyo, CancerCare would like to thank its other sponsors, including its Benefactor: Merck; Patron Sponsor: Eisai; and Contributor Sponsors: Bristol Myers Squibb, Deloitte, GlaxoSmithKline, Janssen Oncology, Doron Krakow & the Krakow family, the Morrone family, Pfizer and PricewaterhouseCoopers. CancerCare is also grateful to this year’s 2023 Festival of Hope Gala Committee Members who helped make the night a success: Joyce Heller, the Morrone Family and Barbara Parmese.
To help further CancerCare's mission of providing help and hope to anyone affected by cancer, please visit: www.cancercare.org/donate.
Founded in 1944, CancerCare is the leading national organization providing free, professional support services and information to help people manage the emotional, practical and financial challenges of cancer. Our comprehensive services include resource navigation, counseling and support groups over the phone, online and in-person, educational workshops, publications and financial and co-payment assistance. All CancerCare services are provided by master’s-prepared oncology social workers and world-leading cancer experts. To learn more, visit our website or call 800-813-HOPE (4673).
About Daiichi Sankyo
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” Daiichi Sankyo is focused on developing essential medicine for longer, better lives. Every day, we strive to put our skills at the service of those most in need. With more than 120 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 17,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.” For more information, please visit www.daiichisankyo.com.